Follitropin beta biosimilar - Reliance Life Sciences

Drug Profile

Follitropin beta biosimilar - Reliance Life Sciences

Alternative Names: FostiRel

Latest Information Update: 03 Oct 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Reliance Life Sciences
  • Class Follicle stimulating hormones; Infertility therapies; Peptide fragments; Pituitary gonadotropins
  • Mechanism of Action Gonadal steroid hormone stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Female infertility; Sex hormone disorders

Most Recent Events

  • 26 Oct 2012 Launched for Female infertility in India (SC) before October 2012
  • 26 Oct 2012 Launched for Sex hormone disorders (spermatogenesis in males) in India (SC) before October 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top